Verified email-pattern data for Solipharm is currently limited. You can still use the company insights and contact sections below.
Avec Solipharm, soyez accompagné, conseillé et faites partie d'un collectif de pharmaciens solidaires afin que chacun soit plus fort pour la croissance de son entreprise.
Solipharm s'adapte au besoin de chaque pharmacie grâce à une offre de service à la carte et à un suivi personnalisé.
Membre de l'alliance Evecial
Company Details
- Founded
- -
- Address
- Région Ouest, Fr
- Industry
- Business Consulting And Services
- Website
- http://www.solipharm.fr
- HQ
- Région Ouest
Solipharm Questions
SOLIPHARM's website is http://www.solipharm.fr
SOLIPHARM's LinkedIn profile is https://fr.linkedin.com/company/solipharm
SOLIPHARM's industry is
Business Consulting and Services
SOLIPHARM's top competitors are
Boticinal,
Groupement Be Pharma,
Dynamis Santé,
La Longue Vue,
Evecial,
Sopharef Sas,
Officinal By Boticinal,
Flexi Plus Pharma - Evecial Group,
Ceido,
Elsie Santé.
SOLIPHARM's categories are Business Consulting and Services
SOLIPHARM's founding year is 2024
Explore related pages
Related company profiles:
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.